Bionano to Present at TD Cowen’s 44th Annual Health Care Conference
Bionano Genomics, Inc. (BNGO) announced that Erik Holmlin, CEO, will present at TD Cowen's Health Care Conference on March 6, 2024. The webcast will be available on their website for 30 days post-conference.
02/29/2024 - 08:00 AM
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s 44th Annual Health Care Conference on March 6, 2024.
Conference & Webcast Details
Date: Wednesday, March 6th, 2024 Time: 12:50 p.m. to 1:20 p.m. ET Presenter: Erik Holmlin, PhD, CEO of Bionano Webcast: Link to Register
A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Bionano’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. Bionano offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, Bionano also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Bionano also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. Bionano additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis technology.
Unless specifically noted otherwise, Bionano’s OGM products are for research use only and not for use in diagnostic procedures.
CONTACTS
Company Contact: eholmlin@bionano.com
Investor Relations: IR@bionano.com
When will Erik Holmlin present at TD Cowen's Health Care Conference?
Erik Holmlin will present on March 6, 2024.
What is the webcast link for the conference?
The webcast link will be available on Bionano's website at https://ir.bionano.com/ for at least 30 days post-conference.
Where can I find a recording of the session after the conference?
A replay/recording of the session will be available on Bionano's website for at least 30 days post-conference.
BNGO Rankings
#5501 Ranked by Stock Gains
BNGO Stock Data
Industry
Testing Laboratories
Sector
Professional, Scientific, and Technical Services
Tags
Health Technology, Biotechnology, Professional, Scientific, and Technical Services, Testing Laboratories
Country
US
City
San Diego
About BNGO
at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o
